Skip to main content

Animations

MJFF Publications

4081 - 4090 of 6465 Results
Title
Year
  • Year
  • 2021
  • 2013
  • 2015
  • 2016
  • 2020
  • 2016
  • 2014
  • 2016
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868
    Citation Count: 188
  • Summary Details
    OPEN
    Title: Screening for impulse control symptoms in patients with de novo Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e31827b915c
    Citation Count: 189
  • Summary Details
    OPEN
    Title: Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-015-0185-3
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000193
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000000711
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000044
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Course of psychiatric symptoms and global cognition in early Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000801
    Citation Count: 121
  • Summary Details
    OPEN
    Title: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0072-9
    Citation Count: 290
  • Summary Details
    OPEN
    Title: NRM 2021 Abstract Booklet
    Journal Name: Journal of Cerebral Blood Flow & Metabolism
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/0271678x211061050
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The 3-Item “Apathy” Subscale Within the GDS-15 Is Not Supported in De Novo Parkinson’s Disease Patients: Analysis of the PPMI Cohort
    Journal Name: Journal of Geriatric Psychiatry and Neurology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/0891988720988908
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.